Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Prepaid Assets (2016 - 2026)

Champions Oncology has reported Prepaid Assets over the past 16 years, most recently at $991000.0 for Q1 2026.

  • For Q1 2026, Prepaid Assets rose 38.99% year-over-year to $991000.0; the TTM value through Jan 2026 reached $991000.0, up 38.99%, while the annual FY2025 figure was $1.4 million, 8.43% down from the prior year.
  • Prepaid Assets for Q1 2026 was $991000.0 at Champions Oncology, down from $1.3 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $1.5 million in Q2 2024 and troughed at $561000.0 in Q1 2022.
  • A 5-year average of $1.0 million and a median of $991000.0 in 2026 define the central range for Prepaid Assets.
  • On a YoY basis, Prepaid Assets climbed as much as 48.49% in 2025 and fell as far as 14.61% in 2025.
  • Year by year, Prepaid Assets stood at $834000.0 in 2022, then fell by 6.47% to $780000.0 in 2023, then grew by 10.26% to $860000.0 in 2024, then soared by 48.49% to $1.3 million in 2025, then decreased by 22.4% to $991000.0 in 2026.
  • Business Quant data shows Prepaid Assets for CSBR at $991000.0 in Q1 2026, $1.3 million in Q4 2025, and $1.2 million in Q3 2025.